Supplemental Subsidiary Guarantors (Details) (USD $) | 3 Months Ended | | |
In Thousands, unless otherwise specified | Jan. 30, 2015 | Jan. 31, 2014 | Oct. 31, 2014 | Oct. 25, 2013 |
Condensed Consolidating Statement of Income | | | | |
Net sales | $703,873 | $839,312 | | |
Cost of sales | 520,746 | 604,178 | | |
Product development, selling and administrative expenses | 137,634 | 153,029 | | |
Other (income) expense, net | -3,213 | -3,140 | | |
Operating income | 48,706 | 85,245 | | |
Income before income taxes | 35,749 | 71,425 | | |
Provision (benefit) for income taxes | 12,155 | 22,564 | | |
Net income | 23,594 | 48,861 | | |
Comprehensive (loss) income | -88,756 | 2,403 | | |
Current assets: | | | | |
Cash and cash equivalents | 152,326 | 290,899 | | |
Accounts receivable, net | 888,675 | | 1,059,709 | |
Inventories | 1,176,048 | | 1,108,308 | |
Other current assets | 174,909 | | 180,151 | |
Total current assets | 2,391,958 | | 2,618,359 | |
Property, plant and equipment, net | 864,719 | | 892,440 | |
Other assets: | | | | |
Other intangible assets, net | 311,029 | | 319,269 | |
Goodwill | 1,493,301 | | 1,516,693 | |
Deferred income taxes | 64,819 | | 70,181 | |
Other non-current assets | 169,281 | | 180,044 | |
Total other assets | 2,038,430 | | 2,086,187 | |
Total assets | 5,295,107 | | 5,596,986 | |
Current liabilities: | | | | |
Short-term notes payable, including current portion of long-term obligations | 16,672 | | 11,739 | |
Trade accounts payable | 322,887 | | 395,945 | |
Employee compensation and benefits | 85,000 | | 136,911 | |
Advance payments and progress billings | 312,401 | | 285,939 | |
Accrued warranties | 58,528 | 77,804 | 67,272 | 85,732 |
Other accrued liabilities | 227,734 | | 265,600 | |
Current liabilities of discontinued operations | 11,582 | | 11,582 | |
Total current liabilities | 1,034,804 | | 1,174,988 | |
Long-term obligations | 1,264,988 | | 1,269,541 | |
Other liabilities: | | | | |
Liabilities for postretirement benefits | 19,290 | | 19,609 | |
Accrued pension costs | 137,252 | | 144,379 | |
Other non-current liabilities | 152,401 | | 147,472 | |
Total other liabilities | 308,943 | | 311,460 | |
Shareholders’ equity | 2,686,372 | | 2,840,997 | |
Total liabilities and shareholders’ equity | 5,295,107 | | 5,596,986 | |
Operating Activities: | | | | |
Net cash provided (used) by operating activities of continuing operations | -18,355 | 64,839 | | |
Net cash provided (used) by operating activities of discontinued operations | 0 | 67 | | |
Net cash (used) provided by operating activities | -18,355 | 64,906 | | |
Investing Activities: | | | | |
Property, plant and equipment acquired | -22,258 | -26,655 | | |
Proceeds from sale of property, plant and equipment | 756 | 2,081 | | |
Other investing activities, net | 141 | -21 | | |
Net cash used by investing activities | -21,361 | -24,595 | | |
Financing Activities: | | | | |
Common stock issued | 273 | 1,985 | | |
Dividends paid | -19,489 | -17,850 | | |
Repayments of term loan | 0 | -12,500 | | |
Treasury stock purchased | -50,000 | -122,036 | | |
Other financing activities, net | 440 | -1,543 | | |
Net cash used by financing activities | -68,776 | -151,944 | | |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | -9,373 | -3,177 | | |
Decrease in Cash and Cash Equivalents | -117,865 | -114,810 | | |
Cash and Cash Equivalents at Beginning of Period | 270,191 | 405,709 | | |
Cash and Cash Equivalents at End of Period | 152,326 | 290,899 | | |
Parent Company | | | | |
Condensed Consolidating Statement of Income | | | | |
Net sales | 0 | 0 | | |
Cost of sales | 0 | 0 | | |
Product development, selling and administrative expenses | 9,848 | 14,669 | | |
Other (income) expense, net | 0 | -473 | | |
Operating income | -9,848 | -14,196 | | |
Intercompany items | 16,770 | 17,278 | | |
Interest (expense) income, net | -15,598 | -16,045 | | |
Income before income taxes | -8,676 | -12,963 | | |
Provision (benefit) for income taxes | 17,492 | -5,054 | | |
Equity in income of subsidiaries | 23,594 | 56,770 | | |
Net income | -2,574 | 48,861 | | |
Comprehensive (loss) income | -114,924 | 2,403 | | |
Current assets: | | | | |
Cash and cash equivalents | 10,550 | 29,665 | | |
Accounts receivable, net | 0 | | 0 | |
Inventories | 0 | | 0 | |
Other current assets | 73,001 | | 87,945 | |
Total current assets | 83,551 | | 142,819 | |
Property, plant and equipment, net | 24,116 | | 23,660 | |
Other assets: | | | | |
Other intangible assets, net | 0 | | 0 | |
Goodwill | 0 | | 0 | |
Deferred income taxes | -6,958 | | 159 | |
Other non-current assets | 4,082,542 | | 4,191,771 | |
Total other assets | 4,075,584 | | 4,191,930 | |
Total assets | 4,183,251 | | 4,358,409 | |
Current liabilities: | | | | |
Short-term notes payable, including current portion of long-term obligations | 4,688 | | 0 | |
Trade accounts payable | 2,306 | | 3,134 | |
Employee compensation and benefits | 6,819 | | 11,639 | |
Advance payments and progress billings | 0 | | 0 | |
Accrued warranties | 0 | | 0 | |
Other accrued liabilities | 71,946 | | 94,097 | |
Current liabilities of discontinued operations | 0 | | 0 | |
Total current liabilities | 85,759 | | 108,870 | |
Long-term obligations | 1,264,979 | | 1,269,459 | |
Other liabilities: | | | | |
Liabilities for postretirement benefits | 18,420 | | 18,743 | |
Accrued pension costs | 124,560 | | 132,448 | |
Other non-current liabilities | 3,161 | | -12,108 | |
Total other liabilities | 146,141 | | 139,083 | |
Shareholders’ equity | 2,686,372 | | 2,840,997 | |
Total liabilities and shareholders’ equity | 4,183,251 | | 4,358,409 | |
Operating Activities: | | | | |
Net cash provided (used) by operating activities of continuing operations | | 61,014 | | |
Net cash provided (used) by operating activities of discontinued operations | | 0 | | |
Net cash (used) provided by operating activities | 25,892 | 61,014 | | |
Investing Activities: | | | | |
Property, plant and equipment acquired | -93 | -3,544 | | |
Proceeds from sale of property, plant and equipment | 0 | 0 | | |
Other investing activities, net | -1,168 | -21 | | |
Net cash used by investing activities | -1,261 | -3,565 | | |
Financing Activities: | | | | |
Common stock issued | 273 | 1,985 | | |
Dividends paid | -19,489 | -17,850 | | |
Repayments of term loan | | -12,500 | | |
Treasury stock purchased | -50,000 | -122,036 | | |
Other financing activities, net | 261 | 284 | | |
Net cash used by financing activities | -68,955 | -150,685 | | |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 0 | 0 | | |
Decrease in Cash and Cash Equivalents | -44,324 | -93,236 | | |
Cash and Cash Equivalents at Beginning of Period | 54,874 | 122,901 | | |
Cash and Cash Equivalents at End of Period | 10,550 | 29,665 | | |
Supplemental Subsidiary Guarantors | | | | |
Condensed Consolidating Statement of Income | | | | |
Net sales | 439,592 | 478,576 | | |
Cost of sales | 319,552 | 361,369 | | |
Product development, selling and administrative expenses | 55,491 | 67,591 | | |
Other (income) expense, net | 4,640 | 2,330 | | |
Operating income | 59,909 | 47,286 | | |
Intercompany items | -23,708 | -19,986 | | |
Interest (expense) income, net | 1,689 | 1,854 | | |
Income before income taxes | 37,890 | 29,154 | | |
Provision (benefit) for income taxes | 3,010 | 27,256 | | |
Equity in income of subsidiaries | 43,472 | 33,013 | | |
Net income | 78,352 | 34,911 | | |
Comprehensive (loss) income | 79,761 | 33,376 | | |
Current assets: | | | | |
Cash and cash equivalents | 3,427 | 6,580 | | |
Accounts receivable, net | 384,043 | | 391,672 | |
Inventories | 490,101 | | 470,194 | |
Other current assets | 13,833 | | 9,520 | |
Total current assets | 891,404 | | 887,815 | |
Property, plant and equipment, net | 338,978 | | 345,117 | |
Other assets: | | | | |
Other intangible assets, net | 224,217 | | 228,950 | |
Goodwill | 453,374 | | 453,374 | |
Deferred income taxes | 0 | | 0 | |
Other non-current assets | 1,941,959 | | 2,106,760 | |
Total other assets | 2,619,550 | | 2,789,084 | |
Total assets | 3,849,932 | | 4,022,016 | |
Current liabilities: | | | | |
Short-term notes payable, including current portion of long-term obligations | 11,896 | | 11,634 | |
Trade accounts payable | 173,583 | | 214,603 | |
Employee compensation and benefits | 34,472 | | 58,374 | |
Advance payments and progress billings | 123,984 | | 117,768 | |
Accrued warranties | 15,175 | | 17,002 | |
Other accrued liabilities | 58,521 | | 54,523 | |
Current liabilities of discontinued operations | 11,582 | | 11,582 | |
Total current liabilities | 429,213 | | 485,486 | |
Long-term obligations | 0 | | 0 | |
Other liabilities: | | | | |
Liabilities for postretirement benefits | 870 | | 866 | |
Accrued pension costs | 8,748 | | 7,529 | |
Other non-current liabilities | 7,978 | | 7,780 | |
Total other liabilities | 17,596 | | 16,175 | |
Shareholders’ equity | 3,403,123 | | 3,520,355 | |
Total liabilities and shareholders’ equity | 3,849,932 | | 4,022,016 | |
Operating Activities: | | | | |
Net cash provided (used) by operating activities of continuing operations | | -9,829 | | |
Net cash provided (used) by operating activities of discontinued operations | | 67 | | |
Net cash (used) provided by operating activities | -7,426 | -9,762 | | |
Investing Activities: | | | | |
Property, plant and equipment acquired | -5,971 | -4,084 | | |
Proceeds from sale of property, plant and equipment | 133 | 1,277 | | |
Other investing activities, net | 0 | 0 | | |
Net cash used by investing activities | -5,838 | -2,807 | | |
Financing Activities: | | | | |
Common stock issued | 0 | 0 | | |
Dividends paid | 0 | 0 | | |
Repayments of term loan | | 0 | | |
Treasury stock purchased | 0 | 0 | | |
Other financing activities, net | 262 | 1,212 | | |
Net cash used by financing activities | 262 | -1,212 | | |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 0 | 0 | | |
Decrease in Cash and Cash Equivalents | -13,002 | -13,781 | | |
Cash and Cash Equivalents at Beginning of Period | 16,429 | 20,361 | | |
Cash and Cash Equivalents at End of Period | 3,427 | 6,580 | | |
Supplemental Non-Guarantor Subsidiaries | | | | |
Condensed Consolidating Statement of Income | | | | |
Net sales | 474,572 | 604,861 | | |
Cost of sales | 364,592 | 447,537 | | |
Product development, selling and administrative expenses | 72,295 | 70,769 | | |
Other (income) expense, net | -7,853 | -4,997 | | |
Operating income | 45,538 | 91,552 | | |
Intercompany items | -6,040 | -9,071 | | |
Interest (expense) income, net | 952 | 371 | | |
Income before income taxes | 40,450 | 82,852 | | |
Provision (benefit) for income taxes | -8,347 | 362 | | |
Equity in income of subsidiaries | 0 | 0 | | |
Net income | 48,797 | 82,490 | | |
Comprehensive (loss) income | -78,111 | 34,786 | | |
Current assets: | | | | |
Cash and cash equivalents | 138,349 | 254,654 | | |
Accounts receivable, net | 527,470 | | 684,299 | |
Inventories | 793,318 | | 753,922 | |
Other current assets | 88,060 | | 82,671 | |
Total current assets | 1,547,197 | | 1,719,780 | |
Property, plant and equipment, net | 506,486 | | 527,286 | |
Other assets: | | | | |
Other intangible assets, net | 86,812 | | 90,319 | |
Goodwill | 1,039,927 | | 1,063,319 | |
Deferred income taxes | 71,777 | | 70,022 | |
Other non-current assets | 2,569,591 | | 2,640,582 | |
Total other assets | 3,768,107 | | 3,864,242 | |
Total assets | 5,821,790 | | 6,111,308 | |
Current liabilities: | | | | |
Short-term notes payable, including current portion of long-term obligations | 88 | | 105 | |
Trade accounts payable | 146,998 | | 178,208 | |
Employee compensation and benefits | 43,709 | | 66,898 | |
Advance payments and progress billings | 215,298 | | 193,165 | |
Accrued warranties | 43,353 | | 50,270 | |
Other accrued liabilities | 104,888 | | 124,244 | |
Current liabilities of discontinued operations | 0 | | 0 | |
Total current liabilities | 554,334 | | 612,890 | |
Long-term obligations | 9 | | 82 | |
Other liabilities: | | | | |
Liabilities for postretirement benefits | 0 | | 0 | |
Accrued pension costs | 3,944 | | 4,402 | |
Other non-current liabilities | 141,262 | | 151,800 | |
Total other liabilities | 145,206 | | 156,202 | |
Shareholders’ equity | 5,122,241 | | 5,342,134 | |
Total liabilities and shareholders’ equity | 5,821,790 | | 6,111,308 | |
Operating Activities: | | | | |
Net cash provided (used) by operating activities of continuing operations | | 13,654 | | |
Net cash provided (used) by operating activities of discontinued operations | | 0 | | |
Net cash (used) provided by operating activities | -36,821 | 13,654 | | |
Investing Activities: | | | | |
Property, plant and equipment acquired | -16,194 | -19,027 | | |
Proceeds from sale of property, plant and equipment | 623 | 804 | | |
Other investing activities, net | 1,309 | 0 | | |
Net cash used by investing activities | -14,262 | -18,223 | | |
Financing Activities: | | | | |
Common stock issued | 0 | 0 | | |
Dividends paid | 0 | 0 | | |
Repayments of term loan | | 0 | | |
Treasury stock purchased | 0 | 0 | | |
Other financing activities, net | -83 | 47 | | |
Net cash used by financing activities | -83 | -47 | | |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | -9,373 | -3,177 | | |
Decrease in Cash and Cash Equivalents | -60,539 | -7,793 | | |
Cash and Cash Equivalents at Beginning of Period | 198,888 | 262,447 | | |
Cash and Cash Equivalents at End of Period | 138,349 | 254,654 | | |
Eliminations | | | | |
Condensed Consolidating Statement of Income | | | | |
Net sales | -210,291 | -244,125 | | |
Cost of sales | -163,398 | -204,728 | | |
Product development, selling and administrative expenses | 0 | 0 | | |
Other (income) expense, net | 0 | 0 | | |
Operating income | -46,893 | -39,397 | | |
Intercompany items | 12,978 | 11,779 | | |
Interest (expense) income, net | 0 | 0 | | |
Income before income taxes | -33,915 | -27,618 | | |
Provision (benefit) for income taxes | 0 | 0 | | |
Equity in income of subsidiaries | -67,066 | -89,783 | | |
Net income | -100,981 | -117,401 | | |
Comprehensive (loss) income | 24,518 | -68,162 | | |
Current assets: | | | | |
Cash and cash equivalents | 0 | | | |
Accounts receivable, net | -22,838 | | -16,262 | |
Inventories | -107,371 | | -115,808 | |
Other current assets | 15 | | 15 | |
Total current assets | -130,194 | | -132,055 | |
Property, plant and equipment, net | -4,861 | | -3,623 | |
Other assets: | | | | |
Other intangible assets, net | 0 | | 0 | |
Goodwill | 0 | | 0 | |
Deferred income taxes | 0 | | 0 | |
Other non-current assets | -8,424,811 | | -8,759,069 | |
Total other assets | -8,424,811 | | -8,759,069 | |
Total assets | -8,559,866 | | -8,894,747 | |
Current liabilities: | | | | |
Short-term notes payable, including current portion of long-term obligations | 0 | | 0 | |
Trade accounts payable | 0 | | 0 | |
Employee compensation and benefits | 0 | | 0 | |
Advance payments and progress billings | -26,881 | | -24,994 | |
Accrued warranties | 0 | | 0 | |
Other accrued liabilities | -7,621 | | -7,264 | |
Current liabilities of discontinued operations | 0 | | 0 | |
Total current liabilities | -34,502 | | -32,258 | |
Long-term obligations | 0 | | 0 | |
Other liabilities: | | | | |
Liabilities for postretirement benefits | 0 | | 0 | |
Accrued pension costs | 0 | | 0 | |
Other non-current liabilities | 0 | | 0 | |
Total other liabilities | 0 | | 0 | |
Shareholders’ equity | -8,525,364 | | -8,862,489 | |
Total liabilities and shareholders’ equity | -8,559,866 | | -8,894,747 | |
Financing Activities: | | | | |
Cash and Cash Equivalents at Beginning of Period | 0 | | | |
Cash and Cash Equivalents at End of Period | 0 | | | |
Consolidated | | | | |
Condensed Consolidating Statement of Income | | | | |
Net sales | 703,873 | 839,312 | | |
Cost of sales | 520,746 | 604,178 | | |
Product development, selling and administrative expenses | 137,634 | 153,029 | | |
Other (income) expense, net | -3,213 | -3,140 | | |
Operating income | 48,706 | 85,245 | | |
Intercompany items | 0 | 0 | | |
Interest (expense) income, net | -12,957 | -13,820 | | |
Income before income taxes | 35,749 | 71,425 | | |
Provision (benefit) for income taxes | 12,155 | 22,564 | | |
Equity in income of subsidiaries | 0 | 0 | | |
Net income | 23,594 | 48,861 | | |
Comprehensive (loss) income | -88,756 | 2,403 | | |
Current assets: | | | | |
Cash and cash equivalents | 152,326 | 290,899 | | |
Accounts receivable, net | 888,675 | | 1,059,709 | |
Inventories | 1,176,048 | | 1,108,308 | |
Other current assets | 174,909 | | 180,151 | |
Total current assets | 2,391,958 | | 2,618,359 | |
Property, plant and equipment, net | 864,719 | | 892,440 | |
Other assets: | | | | |
Other intangible assets, net | 311,029 | | 319,269 | |
Goodwill | 1,493,301 | | 1,516,693 | |
Deferred income taxes | 64,819 | | 70,181 | |
Other non-current assets | 169,281 | | 180,044 | |
Total other assets | 2,038,430 | | 2,086,187 | |
Total assets | 5,295,107 | | 5,596,986 | |
Current liabilities: | | | | |
Short-term notes payable, including current portion of long-term obligations | 16,672 | | 11,739 | |
Trade accounts payable | 322,887 | | 395,945 | |
Employee compensation and benefits | 85,000 | | 136,911 | |
Advance payments and progress billings | 312,401 | | 285,939 | |
Accrued warranties | 58,528 | | 67,272 | |
Other accrued liabilities | 227,734 | | 265,600 | |
Current liabilities of discontinued operations | 11,582 | | 11,582 | |
Total current liabilities | 1,034,804 | | 1,174,988 | |
Long-term obligations | 1,264,988 | | 1,269,541 | |
Other liabilities: | | | | |
Liabilities for postretirement benefits | 19,290 | | 19,609 | |
Accrued pension costs | 137,252 | | 144,379 | |
Other non-current liabilities | 152,401 | | 147,472 | |
Total other liabilities | 308,943 | | 311,460 | |
Shareholders’ equity | 2,686,372 | | 2,840,997 | |
Total liabilities and shareholders’ equity | 5,295,107 | | 5,596,986 | |
Operating Activities: | | | | |
Net cash provided (used) by operating activities of continuing operations | | 64,839 | | |
Net cash provided (used) by operating activities of discontinued operations | | 67 | | |
Net cash (used) provided by operating activities | -18,355 | 64,906 | | |
Investing Activities: | | | | |
Property, plant and equipment acquired | -22,258 | -26,655 | | |
Proceeds from sale of property, plant and equipment | 756 | 2,081 | | |
Other investing activities, net | 141 | -21 | | |
Net cash used by investing activities | -21,361 | -24,595 | | |
Financing Activities: | | | | |
Common stock issued | 273 | 1,985 | | |
Dividends paid | -19,489 | -17,850 | | |
Repayments of term loan | | -12,500 | | |
Treasury stock purchased | -50,000 | -122,036 | | |
Other financing activities, net | 440 | 1,543 | | |
Net cash used by financing activities | -68,776 | -151,944 | | |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | -9,373 | -3,177 | | |
Decrease in Cash and Cash Equivalents | -117,865 | -114,810 | | |
Cash and Cash Equivalents at Beginning of Period | 270,191 | 405,709 | | |
Cash and Cash Equivalents at End of Period | $152,326 | $290,899 | | |